A previous report by the present author (4) described that steroid 3f-ol DH activity was histochemically positive in the endocrine tumors with steroidgenesis (Gardner 107 testicular interstitial cell tumor: 107ICT, and ovarian granulosa cell tumor: GCT) and non-endocrine tumors (transplantable pulmonary tumors showing hyperestrogenism in the hosts) of mice.
From these findings a possibility that steroid 31f1-ol DH activity, which was positive in tumor cells themselves, increased in the host serum with tumor growth and distributed to steroid hormone non-producing organs was supposed. The enzyme activity was very slightly positive histochemically in the normal liver and kidney of mice (1) . If the enzyme activity increases in such organs of the tumor-bearing mice as the kidneys, it will suggest that the enzyme is excreted from them, and it may be significant for the basic research of enzymatic diagnosis in the human cases of these tumors. Therefore, the present study was performed on organdistribution of the enzyme activity derived from the tumors, especially on the kidneys, lungs and livers. At the same time, both G-6-PDH which plays an important role in the steroid biosynthesis (5) and LDH of a glycolytic enzyme were examined on these tumor-bearing mice. In addition, the osteosarcomabearing mice with a marked elevation in serum ALPase activity were studied. * Supported in part by a grant-in-aid for scientific research from the Ministry of Education (Nos. 92352 in 1971 (Nos. 92352 in , 90393 in 1972 , which is sincerely acknowledged.
MATERIALS AND METHODS

Experimental animals and tumors:
The experimental mice and tumors used in this study were the same ones as were described in the previous report by the present author (4) . They are shown in Table 1 . One hundred to two hundreds days old mice weighing 25 g to 35 g were used. Five non-tumor-bearing mice per each tumor group were used as the control group.
Methods of enzyme-histochemistry :
When the above-described tumors had grown large enough, these tumorbearing mice were sacrificed by cerebral trauma without anesthesia, and the tumors, kidneys, lungs and livers were immediately removed. These specimens were divided into two parts. One part was frozen with C02 within ten min. of removal, and cut into 10 µ thick serial sections at 20°C. The sections were used for enzyme histochemistry of steroid 3/l-o1 DH (Wattenberg 1958) (10), of G-6-PDH (Rudolph and Klein l964)(7) and of LDH (Nachlas, Walker and Seligman 1958) (6). The other part was fixed in cold acetone for ALPase activity, using Gomori's azo-dye method (2).
Each level of these enzyme activities was classed in five steps : very high (-H-), high (-H-), moderate (H-), slight (=) and negative (-). RESULTS 
Enzyme-histochemical findings in the tumors
1) Steroid 39-o1 DH 107ICT and GCT always showed a highly positive activity of the enzyme (Figs. 1.2) . No detectable activity of 519OS and AKR/MSOS, used as controls, was demonstrated. These results were similar to those in the previous paper (4).
2) G-6-PDH The activity was moderately to highly positive in both 107ICT and GCT. But this enzyme activity was generally higher in AKR/MSOS than in 519OS.
3) LDH All four different types of tumors showed very highly positive activities in this enzyme, being particularly prominent in GCT and in AKR JMSOS. 4) ALPase 5190S and GCT showed very highly positive in these cell membranes. On Table 2 . 2. Enzyme-histochemical findings in the organs (kidney, lung and liver) of these tumor-bearing mice.
1) Enzyme activity in the kidney a. Steroid 3,3-ol DH The enzyme activity was completely negative in the kidneys of tumor-nonbearing mice. A marked enzyme activity, though varying in degree of intensity depending on sites, was found in areas mostly coinciding with the distal convoluted tubular epithelium, and a dark blue deposit of formazan was found in some lumen of these tubules in 107ICT and GCT (Figs. 3. 4) , but other areas of the kidneys were negative. Such findings of the kidneys were not shown in the osteosarcomabearing mice.
The activity was highly positive in the kidneys of all 107ICT-bearing mice and did not show a sex difference. On the other hand, the activity in GCTbearing female mice was higher than in these of male mice and in ovariectomized ones. The activity levels in GCT-bearing ovariectomized mice were almost comparable to those in male mice.
b. G-6-PDH The enzyme activity was highly to very highly positive in renal tubular epithelium of all tumor-bearing and tumor-non-bearing mice. However, this activity was not observed in the glomeruli.
c. LDH The renal tubuli showed more marked reactions for the enzyme than for G-6-PDH in all mice with or without tumors, and the enzyme activity was also very slightly positive in the glomeruli. There was no significant difference between the GCT and AKRMs/OS-bearing mice. The enzyme activity in the tumor-non-bearing mice was highly positive in the brush borders of the convoluted tubules and very slightly positive in the glomeruli. The kidneys of all thmor-bearing mice also showed the same activities.
These results are summarized in Table 3 . The data show an especially interesting finding that the activity of steroid 39-o1 DH was highly positive in the convoluted tubules of 1O7ICT and GCT-bearing mice; however, the enzyme activity was all negative in kidneys of osteosarcomas and tumor-non-bearing mice. The remaining three enzymes were noted to show almost the same degree of activity in the kidneys of tumor-bearing mice as in those of the tumor-non-bearing mice.
2) Enzyme activities of the lung and the liver The degrees of activities of these enzymes in the lungs and the livers varied with each kind of the enzymes, but no any difference was found between the tumorbearing and the tumor-non-bearing mice.
DISCUSSION
The present study relating to the previous paper (4) was focused on investigating the histochemical activity of steroid 39-ol DH, which may derive from the tumors into the host organs. Steroid 3~9-o1 DH activity was moderately to highly positive in the distal convoluted tubular epithelium of the kidneys in 1O7ICT and GCT-bearing mice. However, the activity was undemonstrable in the kidneys of the tumor non-and the osteosarcoma-bearing mice. This fact was especially interesting and the mechanism will be discussed in the following explanation.
Steroid 39-ol DH activity in 1O7ICT and GCT was always highly positive, but it was completely negative in 519OS and AKR/MsOS. In the kidneys of the tumor-non-bearing mice the activity was also negative. In 1O7ICT and GCT, neither infiltration into the tissues surrounding the well-demarked and encapsulated tumor graft nor distant metastasis to other organs such as the adrenals, ovaries, testes or kidneys was found. Namely, it cannot be considered that the elevated enzyme is released from the steroid hormone-producing organs by those tumor cell infiltrations. Accordingly, steroid 3/3-ol DH derived from the tumor cells seems to arrive at the kidneys via the circulating blood. Formazan deposition observed in the lumen of the distal convoluted tubules also suggests an excretion of the enzymes from the tubular epithelium. The degree of steroid 3/i-ol DH activity in the kidneys of 107ICT mice did not depend upon the sex of the host mouse, but the activity in GCT-bearing female mice was higher than that in the male and ovariectomized mice. Up to now, no report has described findings on the host organs about steroid 33-01 DH activity, which derived from the grafted tumors.
In this study, 51905 showed a marked activity of ALPase in the tumor cells histochemically, and the hosts also showed a marked elevation of the serum ALPase level (8). However, histochemically the activity was not increased in their kidneys, lungs or livers in comparison to that in those of the control group. Jeffree et al. (3) described that human osteogenic sarcomas showed a highly positive ALPase activity in the tumor cells histochemically. Stolbach et al. (9) observed that an ALPase isoenzyme (Regan isoenzyme) had been identified in the serum of 27 patients with various malignant tumors and that 40% to 60% of the total ALPase originated from the tumors themselves, and not from the liver or bone with metastasis. However, these authors did not examine the ALPase activity in the host organs.
ALPase activity elevated in the organs of GCT-bearing mice to about the same level as that in those of the control group, but the tumors themselves showed a highly positive activity histochemically.
The reason why ALPase activity was not increased in the host organs of GCT and 5190S-bearing mice will be briefly speculated as follows. In the first, as the enzyme activity showed very highly positive in the control kidneys etc., it might be difficult to judge the possibly increased activity in the host kidneys, etc., as compared with that in those of the control group histochemically. In the second, the increased activity may not be detected in the host organs, when the increased enzyme is metabolized without condensation and inactivated in them. In the third, the enzyme may not be released from the tumor cells. In the fourth, it may be excreted from other organs or be decomposed in them. These possibilities, except for the third, may be applied to 5190S-bearing mice. However, it is difficult to restrict it to any one of these possibilities in GCT-bearing mice, because the enzyme activity was not examined in the host serum.
Further, G-6-PDH and LDH activities also showed in all the tumors, but these enzyme activities did not increase in the host organs in the present study. The speculation mentioned above may fit for an explanation of the reason.
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